2 results
Approved WMOCompleted
PHASE IIPrimary ObjectiveThe primary objective of the Phase II portion of the study is to estimate the efficacy as measured by radiographic progression-free survival of IPATASERTIB (GDC-0068) (dosed at either 400 mg or 200 mg daily) + abiraterone…
Approved WMOCompleted
Primary objective: To evaluate the performance of the SCP procedure in treatment of bone marrow lesion(s) (BML(s)).Secondary objective:Secondary objectives include documenting clinical outcomes such as pain, function of daily living, function of…